Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial - Wikidata - awgldk - TriplyDB

Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial

Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial

http://www.wikidata.org/entity/Q33798375

about

Hepatitis C Virus, Insulin Resistance, and Steatosis Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes.Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.Insulin resistance and chronic liver disease.HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients.Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review.The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Current understanding of insulin resistance in hepatitis C.Host factors determining the efficacy of hepatitis C treatment.Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience.The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.Insulin resistance in non-diabetic patients of chronic Hepatitis C.Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance.Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus.Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.Natural History of Hepatitis C.

P2860

Q26751755-92FEC837-BD5D-4482-B860-A38AF8565807 Q33988285-1229B4AA-BFAD-4B60-8038-7D01562FB296 Q34172595-4A373CEB-0CEF-4573-8F3D-A4D191E2095A Q35073012-8D7D8ED2-2EF8-44AD-9B9F-F4F1C7C023EA Q35188071-9851D287-940C-4628-BC12-680584E01E45 Q36379566-4D6BFE69-C473-4A0A-811C-50CC2EF8048B Q37151984-8FE7F8F5-0181-459A-A649-38D113FE2782 Q37155511-3AE15CEA-8C43-4A14-88D9-42C8A832A433 Q37513094-698E1F6C-21B5-490F-B3C6-4039F9326CD2 Q37610878-455FB439-8884-487F-9997-8A9E104DDE50 Q37711317-0C1A92C2-83C8-4980-88B4-AF8ED21ED6E3 Q37903853-7A9D203D-AA88-4AC0-AF27-DA8B97445371 Q38056077-499C01FF-7F07-4DA6-A3B1-9B283B110D88 Q38688630-9F1C22CF-C6C2-4616-BDE8-020C5A9BB20F Q40305062-F3F28240-70C4-49B6-9211-DCEA7A31C2DD Q41375331-17EDA2D6-4C47-46A3-A9B2-3979E9F53D96 Q41928201-58E33837-524B-47F4-9FE4-963938988290 Q42024080-78518983-5EE6-43AF-812F-ED4681CABF40 Q42919523-A405C19A-9F6D-4D4A-8B8C-A43894F66793 Q42977335-814363F1-D2C9-4343-88C4-F6E1EDA25E11 Q42977737-B281E481-6EB0-4E5D-BEEC-F20368568840 Q42990259-72A69C3A-6F68-40C6-9B90-2F70A5EA83EC Q45365444-CF4BBBEA-D680-4DF4-8DEE-285E13ABB5C1 Q49942281-1FC95674-EAA2-4F95-AD2F-FE90CA9732D4 Q50934392-88C20250-F5F5-45B3-915A-54266C49CE2F

P2860

Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial

http://www.wikidata.org/entity/Q33798375

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Reduction of insulin resistanc ...... results from the HALT-C trial

@ast

Reduction of insulin resistanc ...... results from the HALT-C trial

@en

type

label

Reduction of insulin resistanc ...... results from the HALT-C trial

@ast

Reduction of insulin resistanc ...... results from the HALT-C trial

@en

prefLabel

Reduction of insulin resistanc ...... results from the HALT-C trial

@ast

Reduction of insulin resistanc ...... results from the HALT-C trial

@en

P1433

Q33798375-7DE3931C-B37F-41D6-8D35-F075D5241B01

P1476

Q33798375-CF13B2C8-6724-4F51-9458-25B591D266DF

P2093

Q33798375-08651C83-3841-4E97-889D-CF8852773BD4

Q33798375-098C5123-EE3F-4BFB-9C95-81646EEF9915

Q33798375-3898906D-0FBA-417E-9A8F-F9702764A50E

Q33798375-39C1193F-B77D-4B57-9CF3-B96F3ECFF643

Q33798375-45F1099F-70DA-4247-B29A-7485A12DE40D

Q33798375-671D46F4-0309-4434-B1C3-2EC75B66F530

Q33798375-6C570C7F-3C6B-4F1D-B97B-A47945A4444C

Q33798375-6D2C7F1A-9922-4A65-93D8-A97655254ACC

Q33798375-A4F7771B-B80D-4DC4-B71D-F18BFC4186E3

Q33798375-CBCA8DF5-23DF-4685-8D3D-C17685FBF014

P2860

Q33798375-03DE436E-51A6-4991-BEAB-6516A52D38D0

Q33798375-07867748-B6E2-4DC1-82A6-2A9DFC07A580

Q33798375-11957817-FE97-40F8-8FD9-C69E4D616020

Q33798375-19C334AD-9C8F-40A2-A5E7-43F1A1ECC47C

Q33798375-1D139D01-4AEE-4EF2-8BD2-DF91C39870E6

Q33798375-2724C067-B984-40CB-8375-96BB01A4D35D

Q33798375-2FDE4818-2767-4875-944B-B8B66D05A8DA

Q33798375-38409D89-772D-47C2-9E20-5AC141E2EAE5

Q33798375-38E7AA89-0D0E-463D-A265-C6FBD1672418

Q33798375-5078936A-FB9D-41D1-B4B1-AE2E5D509E08

P304

Q33798375-7B8C79DB-185A-4C8C-92D1-7BD0CED5254F

P31

Q33798375-C258D1F7-A650-43A2-BA50-1BC15DB2E117

P356

Q33798375-4FE83BB9-EA7F-4EB7-BF3F-A1F0F042F61F

P407

Q33798375-079AA252-0D14-46AE-8BA5-188C05690E1C

P433

Q33798375-B698C54D-60BB-42D3-B0B1-CBD9EB83D476

P478

Q33798375-E72A901D-02E7-435A-8EB3-75FD2D4117E2

P50

Q33798375-2CB4430D-5F45-4429-90FA-F78BF72B6998

P577

Q33798375-60DE6354-21E2-437B-8E9E-192028B4CED1

P5875

Q33798375-4FBFE57B-CEA3-49F3-A2A0-7A34F2A5FAA4

P698

Q33798375-8D170DFB-7442-459E-9EAF-A4757F5771EB

P921

Q33798375-0BD17FDF-3F76-4929-B8E3-7BD5CA295DDA

P932

Q33798375-1CC36E6C-64EF-4E8A-9999-020FEB33D4F0

P356

J.CGH.2010.01.022

P1433

Clinical Gastroenterology and Hepatology

P1476

Reduction of insulin resistanc ...... results from the HALT-C trial

@en

P2093

Anna S F Lok

http://www.w3.org/2001/XMLSchema#string

Aymin Delgado-Borrego

http://www.w3.org/2001/XMLSchema#string

Betania Negre

http://www.w3.org/2001/XMLSchema#string

David A Ludwig

http://www.w3.org/2001/XMLSchema#string

David Healey

http://www.w3.org/2001/XMLSchema#string

Halt-C Trial Group

http://www.w3.org/2001/XMLSchema#string

Marielle Christofi

http://www.w3.org/2001/XMLSchema#string

Sergio H Jordan

http://www.w3.org/2001/XMLSchema#string

Wenyu Lin

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Kamegaya

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Use and abuse of HOMA modeling

Pathologic features of chronic hepatitis. A review and update.

Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance

Hepatitis C virus (HCV) infection and hepatic steatosis

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.

Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

P304

458-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2010.01.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Raymond T Chung

P577

2010-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41435027

http://www.w3.org/2001/XMLSchema#string

P698

20156586

http://www.w3.org/2001/XMLSchema#string

P921

P932

2856733

http://www.w3.org/2001/XMLSchema#string